Provista 002 – Interim Analysis of A Prospective, Multi-Center, Randomized Trial Utilizing the Provista Biomarker Assay in Conjunction with Imaging to Detect Breast Cancer from BIRADS 3 and 4 Patients Ages 25-75

Provista Diagnostics presented this poster at Miami Breast 2015 demonstrating a non-invasive, blood-based combinatorial proteomic biomarker assay (Videssa® Breast) that is to be used as an adjunct to standard-of-care imaging to detect the presence or absence of breast cancer in BIADS 3 and 4 patients Ages 25-75.

Learn more by downloading the scientific poster

HUPO-2016densebreast.png

Download Poster